Gingivitis & Periodontitis

On this page 42 sections
Gingivitis vs periodontitis
| Feature | Gingivitis | Periodontitis |
|---|---|---|
| Inflammation | Present | Present |
| Bleeding on probing | Common | Common |
| Clinical attachment loss | Absent | Present |
| Alveolar bone loss | Absent | Present |
| Periodontal pocket | No true attachment-loss pocket | True periodontal pockets may occur |
| Reversibility | Usually reversible | Lost attachment is not predictably restored by routine treatment |
| Main treatment | Plaque control, oral hygiene and professional cleaning | Periodontal therapy, including subgingival instrumentation; surgery when indicated |
Exam pearl: Bleeding on probing does not, by itself, establish periodontitis. Assess attachment levels and radiographic bone loss.
Color changes in gingivitis
The appearance of inflamed gingiva depends on vascular changes, tissue edema, chronicity and fibrosis.
| Condition | Typical appearance | Mechanism |
|---|---|---|
| Normal gingiva | Coral pink, often stippled | Healthy vascular and connective-tissue architecture |
| Acute gingivitis | Bright red | Vasodilation and increased vascularity |
| Chronic gingivitis | Bluish-red to magenta | Venous congestion and reduced oxygenation |
| Fibrotic gingivitis | Pale pink or nearly normal color | Increased collagen and fibrous tissue may mask inflammation |
| Edematous gingiva | Smooth, shiny, swollen | Increased tissue fluid and loss of normal surface texture |
Remember the color sequence: Normal coral pink → acute bright red → chronic bluish-red.
Fibrotic tissue may appear relatively pale even when inflammation persists.
EXOGENOUS PIGMENTATION OF GINGIVA
Exogenous pigmentation occurs when substances from outside the body accumulate in gingival or oral tissues. This differs from endogenous pigmentation, which results from internal pigments such as melanin, hemosiderin or bilirubin.
| Agent | Typical appearance | Site / mechanism |
|---|---|---|
| Lead | Blue-black line (Burton line) | Gingival margin; lead sulfide deposition |
| Bismuth | Blue-black or greyish line | Gingival margin; bismuth sulfide deposition |
| Mercury | Grey-black line | Gingival margin; mercury sulfide deposits |
| Arsenic | Grey line | Gingival margin; arsenic-related deposits |
| Silver (argyria) | Slate-grey or blue-grey pigmentation | Gingiva and oral mucosa; silver particles in connective tissue |
| Amalgam tattoo | Blue-grey or black focal macule | Gingiva or alveolar mucosa; embedded amalgam particles |
| Tobacco | Brown or melanotic patches | Commonly anterior gingiva; stimulation of melanocytes |
| Betel nut / pan | Dark brown or black staining | Gingiva and teeth; direct staining |
| Iron preparations | Black-green staining | Gingiva or teeth; iron deposits |
| Graphite (pencil) | Dark focal pigmentation | Traumatic implantation, often gingiva or palate |
PATHOGENESIS OF PERIODONTAL DISEASE
Stages of periodontal inflammation
| Stage | Approximate timing | Dominant cells | Main events |
|---|---|---|---|
| Initial lesion | Days 2–4 | Neutrophils (PMNs) | Bacterial penetration, neutrophil migration, early collagen loss |
| Early lesion | Days 4–7 | T-lymphocytes | Increasing inflammatory infiltrate and collagen destruction |
| Established lesion | Days 14–21 | B-lymphocytes / plasma cells | Chronic inflammation; plasma-cell and antibody response |
| Advanced lesion | Weeks to months | Plasma cells + osteoclasts | Attachment loss and alveolar bone resorption; transition to periodontitis |
Cells involved in periodontal disease
| Cell | Main role | FCPS association |
|---|---|---|
| Neutrophils (PMNs) | First-line defense; phagocytose bacteria and release enzymes | Excessive protease activity contributes to collagen destruction |
| Macrophages | Produce IL-1β, TNF-α and PGE₂ | Stimulate inflammation and osteoclast-mediated bone resorption |
| T-lymphocytes | Cell-mediated immunity | Prominent in the early lesion |
| B-lymphocytes / plasma cells | Antibody production | Predominate in established and advanced lesions |
| Osteoclasts | Resorb alveolar bone | Responsible for periodontal bone loss |
| Fibroblasts | Synthesize and maintain collagen | Collagen synthesis may decrease while degradation increases |
| Mast cells | Release histamine and other mediators | Vasodilation and increased vascular permeability |
Mechanism of alveolar bone loss
The central pathway is the RANK–RANKL–OPG system.
- Bacterial biofilm stimulates host inflammatory responses.
- Inflammatory mediators, including IL-1β and TNF-α, promote tissue destruction.
- RANKL binds RANK on osteoclast precursors.
- Osteoclast differentiation and activation increase.
- Alveolar bone is resorbed.
OPG (osteoprotegerin) acts as a decoy receptor that binds RANKL and limits osteoclast activation.
| Factor | Effect |
|---|---|
| RANKL | Promotes osteoclast formation and activation |
| RANK | Receptor on osteoclast precursors |
| OPG | Inhibits RANKL–RANK interaction |
| IL-1β, TNF-α, PGE₂ | Promote inflammatory tissue destruction and can favor bone resorption |
MCQ tip: Osteoclasts resorb alveolar bone; RANKL promotes their activation, whereas OPG inhibits it.
ACUTE NECROTIZING ULCERATIVE GINGIVITIS (ANUG)
Definition and etiology
ANUG is an acute, painful, necrotizing gingival infection historically called Vincent infection or trench mouth.
It is associated with a fusospirochetal microbial community, particularly:
- Fusobacterium nucleatum
- Treponema species, including organisms historically called Borrelia vincentii
Prevotella intermedia may also be involved.
Predisposing factors
- Psychological stress.
- Smoking.
- Poor oral hygiene.
- Malnutrition.
- Sleep deprivation.
- Immunosuppression, including HIV infection.
Clinical features
| Feature | Typical finding |
|---|---|
| Pain | Acute and often severe |
| Papillae | Punched-out, crater-like interdental papillae |
| Bleeding | Spontaneous or on slight provocation |
| Surface | Greyish pseudomembrane |
| Breath | Marked halitosis |
| Other findings | Metallic taste, tender lymph nodes, fever in severe cases |
Classic diagnostic combination
Pain + bleeding + punched-out papillae + halitosis strongly suggests ANUG.
Histological zones of ANUG
The describes four zones, from the surface toward deeper tissues.
| Zone | Main contents |
|---|---|
| Bacterial zone | Mixed bacterial population |
| Neutrophil-rich zone | Dense PMN infiltration |
| Necrotic zone | Dead cells, fibrin, fusobacteria and spirochetes |
| Spirochetal infiltration zone | Deeper penetration of spirochetes into tissue |
Treatment of ANUG
- Gentle professional debridement, initially as tolerated.
- Oral hygiene instruction.
- Antiseptic rinses such as chlorhexidine when appropriate.
- Metronidazole may be indicated when systemic antimicrobial treatment is clinically warranted.
- Address smoking, nutrition, stress and other predisposing factors.
- Assess for systemic illness or immunosuppression when indicated.
Complications
Untreated necrotizing gingival disease can extend into the periodontium as necrotizing ulcerative periodontitis (NUP). In severely malnourished or immunocompromised patients, advanced necrosis may progress to noma.
FCPS tip: In a young patient with ANUG, consider whether HIV testing or other evaluation for immunosuppression is indicated; ANUG alone does not establish HIV infection.
DRUG-INDUCED GINGIVAL OVERGROWTH
Drugs
Certain medications promote excessive gingival enlargement, particularly in the presence of plaque-induced inflammation.
| Drug | Class / indication |
|---|---|
| Phenytoin | Anticonvulsant |
| Cyclosporine | Immunosuppressant |
| Nifedipine | Calcium-channel blocker |
Clinical features
- Enlarged gingival margins and interdental papillae.
- Often more prominent in the anterior gingiva.
- Plaque-induced inflammation can increase the severity.
- Fibrotic enlargement may persist even after inflammation is reduced.
Management
- Improve plaque control and perform professional cleaning.
- Review the medication with the prescribing clinician; consider an appropriate alternative if medically feasible.
- Reassess gingival enlargement after inflammation control and any medically supervised medication change.
- Gingivectomy or another periodontal surgical procedure may be considered if enlargement persists and interferes with function, hygiene or appearance.
FCPS mnemonic: P-C-N = Phenytoin, Cyclosporine, Nifedipine.
Exam pearl: Plaque is an important cofactor. Do not advise a patient to stop an anticonvulsant, immunosuppressant or antihypertensive independently.
COLOR CHANGES IN PERIODONTITIS
Clinical appearance
Periodontal inflammation can change the appearance of the gingiva and periodontal pocket.
| Tissue / finding | Normal appearance | In periodontitis |
|---|---|---|
| Free gingival margin | Coral pink | Red or bluish-red |
| Interdental papilla | Pink and pointed | Red, swollen, blunted or cratered |
| Attached gingiva | Pink and stippled | Erythematous, edematous or less stippled |
| Gingival recession | Margin at an appropriate position relative to the tooth | Root surface becomes exposed |
| Pocket wall | Healthy tissue without pathologic pocketing | Chronically inflamed, often bleeds on probing |
| Purulent exudate | Absent | May indicate suppuration or an abscess |
Remember: Gingival color alone cannot determine whether attachment loss is present. Periodontal probing and appropriate radiographs are needed to assess periodontitis.
PERIODONTITIS: 2017 CLASSIFICATION
Staging: severity and complexity
The 2017 classification replaced the older categories of chronic and aggressive periodontitis with a unified periodontitis diagnosis classified by stage and grade.
Staging reflects the severity of attachment/bone loss and treatment complexity.
| Stage | Interdental clinical attachment loss (CAL) | Radiographic bone loss | Typical complexity |
|---|---|---|---|
| I — Initial | 1–2 mm | Coronal third, less than 15% | Maximum probing depth usually ≤4 mm |
| II — Moderate | 3–4 mm | Coronal third, approximately 15–33% | Maximum probing depth usually ≤5 mm |
| III — Severe | ≥5 mm | Extends to the middle third of the root or beyond | Periodontal tooth loss may be present; furcation involvement and deeper pockets may occur |
| IV — Advanced | ≥5 mm | Extends to the middle third or beyond | Greater tooth loss, masticatory dysfunction or complex rehabilitation needs |
Tooth-loss and furcation criteria as additional stage indicators. Stage assignment should use the complete classification criteria rather than CAL alone.
Grading: rate of progression
Grade estimates the risk and rate of progression, including evidence of progression over time and the relationship between bone loss and age.
| Grade | Progression | General interpretation |
|---|---|---|
| A | Slow | Minimal progression relative to biofilm levels |
| B | Moderate | Progression broadly consistent with biofilm levels |
| C | Rapid | Destruction disproportionate to biofilm levels or documented rapid progression |
The following approximate bone-loss progression figures:
| Grade | Bone loss per year |
|---|---|
| A | Less than 0.25 mm/year |
| B | 0.25–1.0 mm/year |
| C | More than 1.0 mm/year |
Clinical grading should follow the formal classification criteria and available longitudinal or radiographic evidence.
Grade modifiers
- Smoking: more than 10 cigarettes per day supports Grade C.
- Diabetes: HbA1c above 7% supports Grade C in the classification framework.
FCPS tip: Stage = severity and complexity; grade = progression rate and risk.
AGGRESSIVE PERIODONTITIS
The older classification divided aggressive periodontitis into localized and generalized forms. Although the 2017 classification no longer treats aggressive periodontitis as a separate diagnostic category, the terminology remains relevant to some examination questions.
Localized aggressive periodontitis (LAP)
Classic pattern
- Usually begins around puberty or during adolescence.
- Classically affects first permanent molars and incisors.
- Interproximal attachment loss is concentrated around these teeth.
- The amount of plaque may be relatively small compared with the extent of destruction.
- A strong host immune response against Aggregatibacter actinomycetemcomitans (Aa).
Key organism: Aggregatibacter actinomycetemcomitans
- Gram-negative, facultative anaerobic, capnophilic coccobacillus.
- Produces leukotoxin, which damages neutrophils and monocytes.
- May produce collagen-degrading and bone-resorption-associated factors.
- Host neutrophil/monocyte dysfunction can contribute to severe disease.
FCPS tip: Adolescent + first molars and incisors + rapid bone loss disproportionate to plaque = classic localized aggressive periodontitis.
Generalized aggressive periodontitis (GAP)
Clinical pattern
- Usually affects individuals younger than 30 years in the classic description.
- Attachment loss affects at least three permanent teeth other than first molars and incisors.
- Destruction may occur in episodes, with periods of relative quiescence.
- Plaque levels may vary.
- A. actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forsythia.
Systemic associations to remember
Consideration of systemic conditions associated with early-onset aggressive periodontal destruction, including:
- Papillon–Lefèvre syndrome.
- Hypophosphatasia.
- Cyclic neutropenia.
- Leukocyte/neutrophil disorders, including relevant immune deficiencies.
PERIODONTAL PATHOGENS
High-yield organisms
| Organism | Main association | Important feature |
|---|---|---|
| Fusobacterium nucleatum | ANUG, chronic periodontal disease | Bridge organism linking early and late colonizers |
| Treponema species | ANUG; periodontal red complex members include T. denticola | Motile spirochetes; tissue invasion |
| Prevotella intermedia | ANUG, pregnancy gingivitis | Associated with hormonal changes and periodontal inflammation |
| Aggregatibacter actinomycetemcomitans | Classic localized aggressive periodontitis | Leukotoxin; capnophilic |
| Porphyromonas gingivalis | Chronic periodontitis; red complex | Keystone pathogen; produces gingipains |
| Tannerella forsythia | Chronic periodontitis; red complex | Associated with severe periodontal disease |
| Eikenella corrodens | Aggressive periodontal disease | May act synergistically with other pathogens |
| Campylobacter rectus | Periodontal disease; orange complex | Associated with active disease |
| Streptococcus species | Early plaque colonization | Early biofilm colonizers |
Microbial complexes
Socransky's complexes classify subgingival bacteria according to their association with periodontal health and disease.
| Complex | Key organisms | Exam significance |
|---|---|---|
| Red | P. gingivalis, T. forsythia, T. denticola | Strongly associated with periodontitis |
| Orange | F. nucleatum, P. intermedia, C. rectus, P. micra | Associated with disease progression; can facilitate red-complex colonization |
| Yellow | Streptococcus species | Early colonizers |
| Green | Capnocytophaga, A. actinomycetemcomitans serotype a | Early/associated colonizers |
| Purple | Veillonella parvula, Actinomyces odontolyticus | Early colonizers |
Key relationships
- Red complex: Porphyromonas gingivalis + Tannerella forsythia + Treponema denticola.
- Orange complex: Includes Fusobacterium nucleatum and Prevotella intermedia.
- Orange-complex organisms can help establish conditions that favor red-complex colonization.
- F. nucleatum is a bridge organism because it interacts with both early and late plaque colonizers.
FCPS tip: Memorize the three red-complex organisms together; this is a classic microbiology MCQ.
Pregnancy gingivitis
Pregnancy can exacerbate plaque-induced gingival inflammation because increased estrogen and progesterone modify the host response and gingival vascularity.
Key organism
Prevotella intermedia is the classic organism associated with pregnancy gingivitis.
Mechanism
- Increased estrogen and progesterone.
- Greater gingival vascular permeability and altered inflammatory response.
- P. intermedia can use steroid hormones as growth factors.
- Existing plaque produces an exaggerated gingival inflammatory response.
Clinical features
- Red, swollen gingiva.
- Increased bleeding.
- Exaggerated response to plaque without necessarily having a greater plaque burden.
- Pregnancy-associated pyogenic granuloma (pregnancy epulis) may develop, often on the gingiva.
| Organism | Association |
|---|---|
| Prevotella intermedia | Principal organism for pregnancy gingivitis MCQs |
| Porphyromonas gingivalis | May be elevated in pregnancy-associated periodontal disease |
| Fusobacterium nucleatum | Associated with adverse pregnancy outcomes in some studies |
| Campylobacter rectus | Associated with periodontal disease and adverse pregnancy outcomes in some studies |
Exam pearl: Pregnancy gingivitis is primarily an exaggerated response to plaque under hormonal influence; it is not simply an infection caused by pregnancy alone.
MASTER COMPARISON TABLES
Gingivitis vs periodontitis vs ANUG
| Feature | Gingivitis | Periodontitis | ANUG |
|---|---|---|---|
| Main process | Gingival inflammation | Destruction of supporting periodontal tissues | Acute necrotizing gingival inflammation |
| Attachment loss | Absent | Present | Absent initially; may progress to NUP |
| Bone loss | Absent | Present | Absent initially |
| Pain | Usually mild or absent | Variable | Often severe |
| Bleeding | On probing | On probing | Spontaneous or easily provoked |
| Distinctive sign | Erythema, edema, BOP | True pockets, attachment/bone loss | Punched-out papillae, pseudomembrane, halitosis |
| Reversibility | Usually reversible | Attachment loss is not predictably reversed by routine treatment | Often responds to prompt treatment |
| Main management | Plaque control and professional cleaning | Periodontal therapy | Gentle debridement, plaque control and indicated medication |